ha 1004 has been researched along with Lupus Erythematosus, Systemic in 1 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, P | 1 |
| Matzner, WL | 1 |
| Yamiguchi, D | 1 |
| Wallace, D | 1 |
| Klinenberg, JR | 1 |
| Jordan, SC | 1 |
1 other study available for ha 1004 and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Inhibition of protein-kinase C in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: effect on spontaneous immunoglobulin production.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Autoantibodies; Cells, Cultured; Female; Human | 1991 |